Dalle

AI-powered, XR-guided ultrasound platform to democratise diagnostic scanning


Deal Type Equity
Sector HealthTech & Digital Health
Geography UK / Egypt / GCC-relevant markets
Stage / Vintage Early stage
Total Fundraise N/D
Minimum Ticket N/D

Opportunity Overview

Dalle is developing AI-powered, XR-guided ultrasound intended to allow a broader range of healthcare professionals to perform scans. The deck frames ultrasound as trapped in an inefficient, sequential workflow where trained operators must scan, interpret and report before the next patient. Dalle proposes a workflow built around democratised scanning, real-time XR probe alignment, on-device AI validation and rapid tele-reporting. The platform is structured as modular SaaS across clinical training, elective ultrasound and emergency use cases, with target audiences including universities, academic hospitals, hospitals, diagnostic centres, NGOs, EMS crews, field hospitals, combat medics and emergency physicians.

Key Highlights

  • Combines artificial intelligence and extended reality to guide probe positioning and ultrasound image capture.
  • Deck shows potential productivity uplift from around 15 traditional daily scans to 75 under the Dalle workflow.
  • Modular SaaS product lines cover clinical training, elective ultrasound and emergency ultrasound.
  • Use cases include hospitals, diagnostic centres, NGOs, ambulance services, field hospitals and emergency physicians.
  • Team includes clinical, software, AI systems and healthcare innovation experience across the UK, Egypt and Dubai.

GCC Relevance

The GCC relevance is clear: the deck explicitly cites UAE and Saudi ultrasound waiting-time pressure driven by limited trained staff. Dalle could support rural access, emergency care, workforce productivity and AI-enabled diagnostic capacity in fast-growing Gulf health systems.